A Sacramento Bee review of over 100 campaign accounts reveals how lawmakers use their war chests to shore up connections and ...

Research shows that compliance-focused safety training alone rarely delivers lasting risk reduction, prompting calls for ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

Something strange is happening with malnutrition. It’s by far the fastest-growing cause of death in America, soaring sixfold ...

Silence from Scripture on new technologies and the ethical questions they raise is no excuse for silence from the church.

When the flu strikes, it can feel relentless: rising fever, hacking cough, stuffy nose and sore throat. For many people, relief can come in the form of Tamiflu, a prescription antiviral medication ...

For decades, depression treatment has focused almost entirely on the brain, with drugs designed to tweak neurotransmitters like serotonin and dopamine. Now a wave of research is pointing to an ...

Skin bleaching has complications that far outweigh any perceived benefit. We are seeing rising cases of skin cancer, fungal infections resistant to treatment, permanent skin damage, organ toxicity, ...

Welcome to your guide to Pips, the latest game in the New York Times catalogue. Released in August 2025, the Pips puts a ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

The electricity it makes is expensive, its technology has been superseded, and it's incinerating thousands of birds ...